Heart and Neurologic Disease

Heart and Neurologic Disease

1st Edition - February 23, 2021

Write a review

  • Editor: Jose Biller
  • Hardcover ISBN: 9780128198148
  • eBook ISBN: 9780128203897

Purchase options

Purchase options
In Stock
DRM-free (EPub, Mobi, PDF)
Sales tax will be calculated at check-out

Institutional Subscription

Free Global Shipping
No minimum order

Description

The Handbook of Clinical Neurology series volumes provide comprehensive summaries of recent research on the brain and nervous system as they relate to clinical neurology. Cardiac disorders and diseases may often co-occur with, or cause, subsequent neurological disorders. Heart and Neurologic Disease identifies the top cardiac diseases and disorders most likely to have neurological disorders, how they will present, and how they are best treated. It identifies the mechanisms of action explaining why the conditions co-occur, and what clinicians should look for symptom wise, and how risk may be assessed. Coverage includes genetic cardiac disorders, cardiac trauma, surgery, infection, disease, and arrhythmia.

Key Features

  • Identifies the top cardiac diseases and disorders most likely to have neurological complications
  • Specifies how the neurological complication will present and advance and how it should be treated
  • Discusses the mechanism of action—why the two conditions co-occur
  • Includes genetic conditions, trauma, surgery, infection, disease, arrythmias, and more
  • Covers prevention and risk assessment

Readership

Clinical neurologists, researchers in neurology

Table of Contents

  • Cover image
  • Title page
  • Table of Contents
  • Copyright
  • Handbook of Clinical Neurology 3rd Series
  • Foreword
  • Preface
  • Contributors
  • Chapter 1: Neurologic complications of pediatric congenital heart disease
  • Abstract
  • Vascular Complications of Pediatric Congenital Heart Disease
  • Infective Complications of Pediatric Congenital Heart Disease
  • Epilepsy and Pediatric Congenital Heart Disease
  • Neurodevelopmental Sequelae of Pediatric Congenital Heart Disease
  • Chapter 2: Neurologic complications of congenital heart disease in adults
  • Abstract
  • Introduction
  • Classification, Anatomy, and Clinical Presentation of Congenital Heart Disease
  • Cerebrovascular Complications of ACHD
  • Cognitive Impairment and Psychiatric Disease in ACHD
  • Epilepsy
  • Conclusion
  • Chapter 3: Neurologic complications of rheumatic fever
  • Abstract
  • Introduction
  • Historic Vignette
  • Epidemiology
  • Pathophysiology
  • Clinical Presentation
  • Diagnosis
  • Treatment
  • Prognosis
  • Conclusions
  • Chapter 4: Neurologic complications of nonrheumatic valvular heart disease
  • Abstract
  • Calcific Valve Disease
  • Mitral Valve Prolapse
  • Prosthetic Heart Valves
  • Anticoagulation and Its Complications
  • Lambl's Excrescences
  • Chapter 5: Advances and ongoing controversies in PFO closure and cryptogenic stroke
  • Abstract
  • Introduction
  • Diagnosis and Characterization of PFO
  • Diagnosis of Cryptogenic Stroke
  • PFO Closure vs Medical Treatment
  • Patient Selection
  • Conclusions
  • Chapter 6: Neurological complications of coronary heart disease and their management
  • Abstract
  • Introduction
  • Epidemiology
  • Etiology
  • Clinical Presentation, Diagnoses, and Management of Neurological Complications of Coronary Heart Disease
  • Conclusion
  • Chapter 7: Neurologic complications of heart surgery
  • Abstract
  • Introduction
  • Acute Ischemic Stroke
  • Other Types of Ischemic Complications
  • Hemorrhagic Stroke
  • Seizures
  • Cognitive Decline
  • Psychological Complications
  • Contrast Neurotoxicity
  • Peripheral Nerve Injuries
  • Chapter 8: Neurological complications of heart failure
  • Abstract
  • Introduction
  • Etiology of Heart Failure
  • Heart Failure and Atrial Fibrillation
  • Physiological Brain Changes in HF Patients
  • Neurological Complications Associated With Heart Failure
  • Chapter 9: Neurological complications of cardiomyopathies
  • Abstract
  • Definition, Classification and Clinical Update
  • Neurological Manifestations of Cardiomyopathies
  • Cerebrovascular Complications
  • Neuromuscular Disorders
  • Chapter 10: Neurologic complications of myocarditis
  • Abstract
  • Neurological Complications of Myocarditis
  • Myocarditis, General Principles
  • Diagnosis of Myocarditis
  • Covid-19 Myocarditis
  • Myocarditis and Myasthenia Gravis Associations
  • Conclusions and Future Directions
  • Chapter 11: Neurologic complications of infective endocarditis
  • Abstract
  • Introduction
  • Diagnosis of Infective Endocarditis
  • General Management of Infective Endocarditis
  • Ischemic Stroke
  • Intracerebral Hemorrhage
  • CNS Infections
  • Conclusions
  • Chapter 12: Neurologic complications of nonbacterial thrombotic endocarditis
  • Abstract
  • Introduction
  • Epidemiology
  • Pathogenesis
  • Clinical Symptomatology
  • Diagnosis
  • Differential Diagnosis
  • Management
  • Prognosis
  • Conclusion
  • Chapter 13: Neurologic complications of atrial fibrillation: Pharmacologic and interventional approaches to stroke prevention
  • Abstract
  • Introduction
  • Risk Stratification
  • Pharmacologic Therapies
  • Nonpharmacologic Therapies or Left Atrial Appendage Closure
  • Conclusion
  • Chapter 14: Tachyarrhythmias and neurologic complications
  • Abstract
  • Atrioventricular Electrophysiology and the Autonomic System
  • Types of Tachyarrhythmia
  • Atrial Tachycardia
  • AVNRT and AVRT
  • Ventricular Tachycardia
  • Ventricular Fibrillation and Flutter
  • Torsade De Pointes
  • Conclusion
  • Chapter 15: Neurologic complications of brady-arrhythmias
  • Abstract
  • Neurologic Complications of Brady-Arrhythmias
  • Background Physiology
  • Neurologic Complications
  • Chapter 16: Effects of acute neurologic disease on the heart
  • Abstract
  • Introduction
  • Normal Physiology
  • Brain
  • Spinal Cord
  • Peripheral Nerve
  • Neuromuscular Junction
  • Conclusion
  • Chapter 17: Neurologic complications of genetic channelopathies
  • Abstract
  • Long QT Syndrome and Deafness
  • Andersen-Tawil Syndrome (ATS)
  • Timothy Syndrome
  • Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) and Seizures
  • Brugada Syndrome and Seizures
  • Sinoatrial Node Dysfunction and Deafness
  • Conclusion
  • Chapter 18: Neurological complications of syncope and sudden cardiac arrest
  • Abstract
  • Mechanism of Syncope
  • Cardiac Arrhythmia With Cerebral Hypoperfusion
  • Sudden Cardiac Death With Possible Neurological Interaction
  • Summary
  • Chapter 19: Neurologic complications of cardiac arrest
  • Abstract
  • Introduction
  • Pathophysiology of Brain Injury in Cardiac Arrest
  • Interventions
  • Prognostication of Neurologic Outcome
  • Conclusion
  • Chapter 20: Neurologic complications of implantable devices
  • Abstract
  • Heart Valve Replacement
  • Implanted Devices for Secondary Stroke Prevention
  • Implantable Mechanical Circulatory Support Devices
  • Chapter 21: Neurologic complications of diseases of the aorta
  • Abstract
  • Introduction
  • Spinal Cord Vascular Supply
  • Neurologic Complications of Aortic Disease
  • Neurologic Complications of Aortic Surgery
  • Conclusion
  • Chapter 22: Cerebral aneurysms and cervical artery dissection: Neurological complications and genetic associations
  • Abstract
  • Introduction
  • Neurologic Complications of Intracranial Aneurysms
  • Neurologic Complications of Cervical Artery Dissection
  • Monogenic Syndromes Associated with Aneurysms and Dissection
  • Polygenic Associations of Aneurysms and Dissection
  • Conclusion/Summary
  • Chapter 23: Neurological complications of systemic hypertension
  • Abstract
  • Introduction and Background
  • Hypertensive Encephalopathy
  • Stroke
  • Intracranial Atherosclerosis and Hypertrophic Remodeling
  • Cognitive Impairment and Dementia
  • Chapter 24: Neurologic complications of venous thromboembolism
  • Abstract
  • Introduction
  • Risk of Ischemic Cerebrovascular Disease After VTE
  • Intracranial Hemorrhage Following VTE
  • VTE as the Initial Manifestation of Brain Tumors
  • Peripheral Nervous System Complications of VTE
  • Conclusions
  • Chapter 25: Neurologic complications of cardiac disease in athletes
  • Abstract
  • Introduction
  • Athlete's Heart
  • Cardiac Rhythm Changes Among Athletes
  • Neurological Manifestation of Cardiac Disease Among Athletes
  • Summary
  • Chapter 26: Cerebrovascular manifestations of tumors of the heart
  • Abstract
  • Introduction
  • General Clinical Presentations of Cardiac Tumors
  • Other Primary Tumors
  • Metastatic Heart Tumors
  • Conclusions
  • Chapter 27: Stroke in pregnancy
  • Abstract
  • Epidemiology
  • Etiology
  • Management
  • Chapter 28: Hemodynamics in acute stroke: Cerebral and cardiac complications
  • Abstract
  • Introduction
  • Hemodynamic Changes in Acute Ischemic Stroke
  • Implications of Hemodynamics for Selecting Patients for Revascularization Procedures
  • Enhancing Hemodynamics in Acute Stroke
  • Conclusion
  • Chapter 29: Neurological complications of cardiovascular drugs
  • Abstract
  • Introduction
  • Antihypertensive Drugs
  • Diuretics
  • Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
  • Calcium Channel Blockers
  • Alpha 1-Adrenergic Receptor Blockers
  • Beta-Adrenergic Blockers
  • Vasodilators
  • Cholesterol-Lowering Drugs
  • Statins
  • Cholesterol Absorption Inhibitor, Ezetimibe
  • Fibric Acid Derivatives
  • PCSK9 Inhibitors
  • Antiarrhythmic Drugs
  • Antiplatelet Drugs
  • Aspirin
  • P2Y12 Receptor Inhibitors
  • Glycoprotein IIb/IIIa Inhibitors
  • Anticoagulant Drugs
  • Vitamin K Antagonists, Warfarin
  • Direct Oral Anticoagulants
  • Heparin, Enoxaparin, and Fondaparinux
  • Parenteral Thrombin Inhibitors
  • Fibrinolytics
  • Heart Failure Drugs
  • Antianginal Drugs
  • Future Directions
  • Chapter 30: The role of biomarkers and neuroimaging in ischemic/hemorrhagic risk assessment for cardiovascular/cerebrovascular disease prevention
  • Abstract
  • Introduction
  • Stratification of Embolic Stroke Risk in AF
  • Stratification of Hemorrhagic Stroke Risk in AF
  • Prevention of Ischemic Stroke in Patients With AF at Low Hemorrhagic Risk
  • Prevention of Ischemic and Hemorrhagic Strokes/Events in Patients With AF at High Hemorrhagic Risk
  • Risk Stratification Methods and Antiplatelet Use
  • Conclusions
  • Study support
  • Chapter 31: Clinical utility of echocardiography in secondary ischemic stroke prevention
  • Abstract
  • Introduction
  • Therapeutic Relevance of Echocardiographic Findings in Acute Cerebral Ischemia
  • TTE vs TTE for Detection of Therapeutically Relevant Cardiac Pathologies
  • Clinical Correlations and Associations With Therapeutically Important Cardiac Pathologies
  • Cost-Effectiveness Studies
  • Summary and Conclusions
  • Chapter 32: The relationship between heart disease and cognitive impairment
  • Abstract
  • Introduction
  • Coronary Heart Disease
  • Congestive Heart Failure and Low Output States
  • Atrial Fibrillation
  • Atrial Cardiomyopathy
  • Cardiovascular Risk Factors and Cognitive Impairment
  • Links Between Vascular Risk Factors and Neurodegeneration
  • Interventional Trials
  • Conclusions
  • Chapter 33: Anxiety and psychological management of heart disease and heart surgery
  • Abstract
  • Introduction
  • Overview of Anxiety and Heart Disease
  • Anxiety and Vascular Risk Factors
  • Physiology of Anxiety
  • Neurologic Manifestations of Anxiety and Heart Disease
  • Assessment and Diagnosis of Anxiety
  • Prevention and Treatment of Anxiety Disorders
  • Prevention and Treatment
  • Conclusions
  • Index

Product details

  • No. of pages: 440
  • Language: English
  • Copyright: © Elsevier 2021
  • Published: February 23, 2021
  • Imprint: Elsevier
  • Hardcover ISBN: 9780128198148
  • eBook ISBN: 9780128203897

About the Series Volume Editor

Jose Biller

José Biller, M.D., FACP, FAAN, FANA, FAHA

Loyola University Chicago, Maywood, IL, USA

Dr. José Biller is Professor of Neurology and Neurological Surgery and Chairperson of the Department of Neurology at Loyola University Chicago Stritch School of Medicine. Dr. Biller served as Director of the American Board of Psychiatry and Neurology (ABPN) from 1994 to 2001, and President of the ABPN in 2001. He is Chief Editor of the Journal of Stroke and Cerebrovascular Diseases , and an editorial board member and reviewer for an array of other national and international journals and publications. He is a Fellow of the American Academy of Neurology, American Neurological Association, American College of Physicians, and the Stroke Council of the American Heart Association. He has published more than 370 peer-reviewed articles, more than 150 book chapters, and numerous books.

Affiliations and Expertise

Neurology, Professor and Chairman, Department of Neurology, Loyola University Chicago, Stritch School of Medicine, Maywood, IL, USA

Ratings and Reviews

Write a review

There are currently no reviews for "Heart and Neurologic Disease"